Prednisolone + OfloxacinThird Party Manufacturing in India

Prednisolone + Ofloxacin Eye Drops provide a synergistic combination of anti-inflammatory and broad-spectrum antibacterial activity for the management of steroid-responsive ocular conditions with concurrent bacterial infection risk.

Prednisolone is a glucocorticoid that suppresses inflammation by binding to cytosolic glucocorticoid receptors, which then modulate gene expression to reduce the production of pro-inflammatory cytokines, prostaglandins, and leukotrienes. It inhibits phospholipase A2 activity, reducing arachidonic acid release from membrane phospholipids. This action decreases vascular permeability, leukocyte migration, and fibroblast activity at the site of inflammation, bringing rapid relief from ocular redness, swelling, and pain.

Ofloxacin is a second-generation fluoroquinolone that acts by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA supercoiling and replication. This leads to bacterial cell death. Ofloxacin demonstrates good activity against both aerobic Gram-positive organisms such as Staphylococcus aureus and Streptococcus species, as well as Gram-negative organisms including Haemophilus influenzae and Pseudomonas aeruginosa.

This combination ensures comprehensive coverage: prednisolone controls the inflammatory component while ofloxacin eliminates or prevents bacterial infection, making it especially valuable in clinical settings where both therapeutic effects are required simultaneously.

Therapeutic Uses

Prednisolone + Ofloxacin Eye Drops are prescribed for:

• Post-Surgical Inflammation with Infection Risk: Standard post-operative regimen following cataract extraction, trabeculectomy, and corneal surgeries
• Bacterial Conjunctivitis with Marked Inflammation: Treats purulent conjunctivitis where significant inflammatory response requires corticosteroid control
• Blepharitis and Blepharoconjunctivitis: Controls eyelid margin inflammation while treating associated bacterial colonization
• Corneal Ulcers (with appropriate antibiogram): Provides anti-inflammatory coverage to reduce scarring during antibiotic treatment
• Prevention of Post-Traumatic Endophthalmitis: Used in penetrating eye injuries where both inflammation and infection are concerns

Why Manufacturers Choose This Combination

The prednisolone-ofloxacin fixed-dose combination is one of the most commonly prescribed ophthalmic preparations in India and across emerging markets. It offers the advantage of dual therapy in a single drop, simplifying dosing regimens and improving patient adherence. Hospitals prefer this combination for post-operative discharge prescriptions, creating high-volume institutional demand.

Indian ophthalmic contract manufacturers with WHO-GMP sterile manufacturing lines produce this product for both domestic PCD franchise networks and export to over 30 countries. The combination is a priority product line for third party manufacturing in India, with established raw material supply chains and proven formulation stability.